Desensitization in Kidney Transplantation

NCT00908583 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

HLA Sensitization

Interventions

DRUG: plasmapheresis
DRUG: Bortezomib
DRUG: Rituximab
DRUG: Methylprednisolone

Sponsor

University of Cincinnati

Collaborators

[object Object]